by Microcrystalline cellulose is one of the most commonly used excipients in the pharmaceutical industry. It acts as a multifunctional additive that improves the flowability and compressibility of tablets and enhances texture in various solid dosage forms. Microcrystalline cellulose improves drug delivery by extending drug release, reducing dissolution times and protecting unstable drugs from degradation. It is also used as an adsorbent, thickening and stabilizing agent in various food and cosmetic products.
The Global Microcrystalline Cellulose Market is estimated to be valued at US$ 1349.84 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the microcrystalline cellulose are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio, Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG, Hamilton Company, ZS Genetics, Inc. LI-COR, Inc.
Growing demand for microcrystalline cellulose from industries such as pharmaceutical and food & beverage is expected to boost market growth during the forecast period. It is extensively used as an excipient in tablets and capsules owing to its multifunctional properties.
The global microcrystalline cellulose market is also expanding rapidly with rising demand from emerging economies in Asia Pacific and Latin America. Countries like India, China, Brazil and Mexico are projected to witness strong growth due to rising population, growing per capita incomes and flourishing pharmaceutical industry.
Market Key Trends
One of the key trends gaining prominence in the microcrystalline cellulose market is the increasing use of microcrystalline cellulose in controlled and sustained drug delivery applications. Its texturing and disintegrating properties allow developing formulations for extended and targeted release of active pharmaceutical ingredients. This enhances patient compliance and therapeutic effectiveness of drugs. Various ongoing R&D activities are expanding applications of microcrystalline cellulose in novel drug delivery systems.
Porter’s Analysis
Threat of new entrants: The microcrystalline cellulose market requires substantial investments in R&D and manufacturing infrastructure which poses high entry barriers for new players.
Bargaining power of buyers: The bargaining power of buyers in the microcrystalline cellulose market is moderate as buyers have limited options and are somewhat dependent on established manufacturers.
Bargaining power of suppliers: Major suppliers in the microcrystalline cellulose market possess moderate bargaining power due to high production costs and investments required.
Threat of new substitutes: No cost-effective substitutes are available for microcrystalline cellulose due to its unique functional properties.
Competitive rivalry: The microcrystalline cellulose market is moderately competitive with the presence of tier-1 manufacturers globally.
Geographical Regions
North America accounted for the largest share of the global microcrystalline cellulose market in terms of value in 2024 owing to extensive usage of MCC in pharmaceutical applications in the region. The United States held a major share of the North American market.
The Asia Pacific region is expected to grow at the fastest rate during the forecast period driven by increasing demand from end-use industries like food and pharmaceuticals in emerging economies such as China and India. Growth in the pharmaceutical industry across Asia Pacific is fueling MCC demand.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile